Document Detail


Peripheral arterial disease. Medical management in primary care practice.
MedLine Citation:
PMID:  11301719     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Peripheral arterial disease (PAD) is caused by atherosclerosis, the leading cause of death and disability in patients age 50 and older. PAD progresses gradually and silently over many years, occluding the lumen of arteries that supply blood to the extremities. Symptoms of peripheral arterial insufficiency include intermittent claudication, rest pain, and impotence. Nonoperative management--including the control of risk factors such as hypertension, diabetes, hyperlipidemia, and smoking--is the most effective method to lower the risk of morbidity from PAD. Diagnostic technologies such as color duplex imaging, MRI, and MRA complement the clinical assessment of PAD and provide a stronger foundation for treatment decisions in the primary care setting.
Authors:
S D Weiner; E D Reis; M D Kerstein
Related Documents :
7777439 - Peripheral arterial disease. when to consider percutaneous revascularization.
542949 - Management of concomitant occlusive disease of the supraaortic and lower-limb arteries.
8810979 - Arterial bullet embolism resulting in delayed vascular insufficiency: a rationale for m...
11570659 - Association between erythrocyte mean corpuscular volume and peripheral arterial disease...
1942159 - Peripheral arterial shotgun missile emboli: diagnostic and therapeutic management--case...
848239 - Our experience in lumbar ganglionectomy. a critical comparison of the 1950-1965 and the...
9090429 - The accessory middle cerebral artery as a collateral blood supply.
15580489 - Mr angiography of the intracranial vessels: technical aspects and clinical applications.
24059769 - Evaluation of balloon occlusion test for giant brain aneurysms under local anaesthesia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Geriatrics     Volume:  56     ISSN:  0016-867X     ISO Abbreviation:  Geriatrics     Publication Date:  2001 Apr 
Date Detail:
Created Date:  2001-04-13     Completed Date:  2001-05-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985102R     Medline TA:  Geriatrics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  20-2, 25-6, 29-30     Citation Subset:  AIM; IM    
Affiliation:
Mount Sinai School of Medicine, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antilipemic Agents / therapeutic use
Arteriosclerosis / physiopathology
Diabetic Angiopathies / diagnosis,  therapy
Family Practice
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Magnetic Resonance Imaging
Middle Aged
Peripheral Vascular Diseases / diagnosis*,  epidemiology,  physiopathology,  therapy*
Risk Factors
Chemical
Reg. No./Substance:
0/Antilipemic Agents; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Asthma--a condition of our time, a condition in change?
Next Document:  Prostatitis. Work-up and treatment of men with telltale symptoms.